the discovery and development of liraglutide and semaglutide Structure half-lives native human GLP-1, Approaches for half-life extension of

H2 Blockers Medications like famotidine (Pepcid) reduce acid production

GLP-1 drugs represent a major advance in metabolic health, with clinical trials showing 15-22% body weight reduction in patients over one year

GSHs solubility and stability in aqueous buffers allow extended use in redox-sensitive assays and modeling of thiol-dependent biochemical pathways

From Uric Acid Metabolism to Gouty Inflammation: Model Strategies for Preclinical Research Bridging the Species Gap in Hyperuricemia and Gout Research: Humanized Mouse Models for Translational Drug Discovery Hyperuricemia and gout are becoming increasingly important areas in metabolic and inflammatory disease research